Detalles de la búsqueda
1.
Comparison of the Speed of Enrollment for Clinical Trials Conducted by Japanese and Global Pharmaceutical Companies.
Biol Pharm Bull
; 46(9): 1289-1295, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37661408
2.
Real-World Predictors of Severe Neutropenia Associated with Palbociclib and Endocrine Therapy for Metastatic Breast Cancer in Japanese Patients.
Biol Pharm Bull
; 46(8): 1105-1111, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37532561
3.
A Novel Method for Quantifying Plant Morphological Characteristics Using Normal Vectors and Local Curvature Data via 3D Modelling-A Case Study in Leaf Lettuce.
Sensors (Basel)
; 23(15)2023 Jul 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-37571608
4.
Lag Time for New Innovative, First-in-Class, Drug Approval in Japan.
Biol Pharm Bull
; 45(4): 477-482, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35370272
5.
Relationships between developmental strategies for additional indications and price revisions for anticancer drugs in Japan.
BMC Health Serv Res
; 21(1): 1329, 2021 Dec 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34895223
6.
TAT-dextran-mediated mitochondrial transfer enhances recovery from models of reperfusion injury in cultured cardiomyocytes.
J Cell Mol Med
; 24(9): 5007-5020, 2020 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-32212298
7.
Real-time 400 Gbps/carrier WDM transmission over 2,000â km of field-installed G.654.E fiber.
Opt Express
; 28(2): 1640-1646, 2020 Jan 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-32121871
8.
Efficacy and safety of a 3-month dosing regimen of degarelix in Japanese patients with prostate cancer: a phase II maintenance-dose-finding study.
Jpn J Clin Oncol
; 47(5): 438-446, 2017 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28334771
9.
A multicenter phase I/II study of enzalutamide in Japanese patients with castration-resistant prostate cancer.
Int J Clin Oncol
; 21(4): 773-782, 2016 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-26793974
10.
[â .Changes of Developmental Strategy and Procedure of Clinical Trials for Anticancer Drugs against Urological Cancer-Our Challenge and Future Perspective].
Gan To Kagaku Ryoho
; 48(1): 27-34, 2021 Jan.
Artículo
en Japonés
| MEDLINE | ID: mdl-33468719
11.
Recent trends for drug lag in clinical development of oncology drugs in Japan: does the oncology drug lag still exist in Japan?
Int J Clin Oncol
; 20(6): 1072-80, 2015 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-25837976
12.
A phase I study of combination therapy with nanoparticle albumin-bound paclitaxel and cyclophosphamide in patients with metastatic or recurrent breast cancer.
Int J Clin Oncol
; 20(3): 474-9, 2015 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-25073954
13.
Measurement of maternal cerebral tissue hemoglobin on near-infrared time-resolved spectroscopy in the peripartum period.
J Obstet Gynaecol Res
; 41(6): 876-83, 2015 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-25512224
14.
Differences in maximum tolerated doses and approval doses of molecularly targeted oncology drug between Japan and Western countries.
Invest New Drugs
; 32(4): 661-9, 2014 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-24615632
15.
[Enzalutamide-a novel androgen receptor inhibitor that provides treatment options for patients with castration-resistant prostate cancer].
Gan To Kagaku Ryoho
; 41(7): 805-10, 2014 Jul.
Artículo
en Japonés
| MEDLINE | ID: mdl-25131864
16.
Adult and pediatric relapsing multiple sclerosis phase II and phase III trial design and their primary end points: A systematic review.
Clin Transl Sci
; 17(5): e13794, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38708586
17.
Current situation and issues regarding termination of risk management plans in Japan.
Front Med (Lausanne)
; 11: 1387652, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38873195
18.
Overall survival in Japanese patients with ER+/HER2- advanced breast cancer treated with first-line palbociclib plus letrozole.
Breast Cancer
; 31(1): 53-62, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-37882974
19.
Risk Factors for Eribulin-induced Severe Neutropenia in Patients With Recurrent Breast Cancer.
In Vivo
; 38(1): 500-505, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38148090
20.
Involvement of anticancer drugs in the relief system for adverse drug reactions in Japan.
Jpn J Clin Oncol
; 43(12): 1273-81, 2013 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-24068711